KalVista Pharmaceuticals Inc (KALV) Stock Price, Quote, News & History

KALVNASDAQ
$27.00
At close: Jun 12, 5:00 PM EST
$26.99
-0.01-0.04%
After Hours: Jun 10, 6:32 PM EST
M&A: KalVista Pharmaceuticals (KALV) was merged with Chiesi Group on Thursday, June 11, 2026

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
-
Free Cash Flow (TTM)
-
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-

Analyst Trends and Forecast

3
Jan
2
Mar
0
0
0
0
Apr
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.30B
PE Ratio (TTM)
-
PE Ratio (FWD)
25.45
PEG Ratio (TTM)
-
PS Ratio (TTM)
974.52
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-14.59%
Earnings Yield % (FWD)
3.93%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.37

Company Debt

Total Debt
$139.40M
LT Debt
$139.40M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$213.77M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 3.45M
Day Range
- - -
52 Wk Range
9.83 - 27.00
Market Cap
$1.44B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
-
Short Interest
-
Days to Cover
1.97

About

Sector
N/A
Industry
N/A
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discove...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy KalVista Pharmaceuticals (KALV) stock?

A

You can purchase shares of KalVista Pharmaceuticals (NASDAQ:KALV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are KalVista Pharmaceuticals (KALV) competitors?

A

There are no as such competitors for KalVista Pharmaceuticals.

Q

What is the forecast, or price target, for KalVista Pharmaceuticals (KALV) stock?

A

KalVista Pharmaceuticals has a consensus price target of $28.30.

Q

What is the current price for KalVista Pharmaceuticals (KALV)?

A

The stock price for KalVista Pharmaceuticals (NASDAQ: KALV) is $26.99 last updated June 10, 2026 at 6:32 PM EDT.

Q

Does KalVista Pharmaceuticals (KALV) pay a dividend?

A

There are no upcoming dividends for KalVista Pharmaceuticals.

Q

When is KalVista Pharmaceuticals (NASDAQ:KALV) reporting earnings?

A

KalVista Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is KalVista Pharmaceuticals (KALV) going to split?

A

There is no upcoming split for KalVista Pharmaceuticals.

Q

What sector and industry does KalVista Pharmaceuticals (KALV) operate in?

A

KalVista Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.